Digital major care supplier K Health introduced it secured $50 million in an fairness funding spherical.
Claure Group led the spherical with participation from Pablo Legorreta, the founder and CEO of Royalty Pharma. Present buyers Valor Fairness Companions, Mangrove Capital Companions and Atreides Administration LP additionally joined the spherical.
WHAT IT DOES
Ok Well being is an AI-enabled digital care supplier that gives major care, pressing care, psychological well being and medical weight administration companies.
The corporate affords an AI-powered platform aimed toward streamlining the supplier expertise. Sufferers bear an evaluation by way of an AI chat. That info is then mixed with related EMRs and provides suppliers with a medical chart with personalised insights.
New York-based Ok Well being will use the funds to broaden its attain inside healthcare programs and advance its AI improvements.
“As I spend money on the AI panorama, I’ve discovered it extremely tough to find corporations making tangible, real-world progress with AI,” Marcelo Claure, founder and CEO of Claure Group, mentioned in a press release.
“Ok Well being is the primary firm I’ve seen efficiently utilizing AI to affect tens of millions of lives. They’re addressing a few of healthcare’s biggest challenges by offering accessibility to sooner, higher-quality, lower-cost care on a big scale.”
MARKET SNAPSHOT
In 2023, the corporate raised $59 million in a down spherical. The funding got here from its current buyers and California-based hospital system Cedars Sinai.
It additionally partnered with Cedars-Sinai to broaden the Los Angeles-based well being programs’ digital care choices for sufferers. The organizations collaborated to develop Cedars-Sinai Connect, a digital healthcare platform powered by Ok Well being’s AI know-how.
Earlier this yr, the corporate introduced it entered right into a know-how settlement with the Mayo Clinic to develop a scientific AI-enabled answer for cardiac care meant to forestall untimely deaths from stroke or coronary heart illness.
Ok Well being licensed de-identified knowledge from Mayo to refine its AI and create new algorithms aimed toward serving to physicians predict danger and therapy choices by analyzing components comparable to medical historical past, race, age and gender.
